Vitamin D receptor gene polymorphisms and HLA DRB1*04 cosegregation in Saudi type 2 diabetes patients

Journal of Immunology

Volumn 188, Issue 3, 2012, Pages 1325-1332

  Al Daghri, Nasser M ^a,b   Al Attas, Omar ^a,b   Alokail, Majed S ^a,b   Alkharfy, Khalid M ^a,b,c   Draz, Hossam M ^a   Agliardi, Cristina ^d   Mohammed, Abdul Khader ^a   Guerini, Franca R ^d   Clerici, Mario ^a,d,e  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CD14 ANTIGEN; CD16 ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; GENOMIC DNA; HIGH DENSITY LIPOPROTEIN; HLA DRB1 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 6; VITAMIN D RECEPTOR;

ADULT; ALLELE; ARTICLE; BSM 1 GENE; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; EXON; EXON 2; EXON 9; FLUORESCENCE ACTIVATED CELL SORTING; FOK 1 GENE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEGREGATION; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; INTRON 8; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR GENE; SAUDI ARABIA; SINGLE NUCLEOTIDE POLYMORPHISM; TAQ 1 GENE; VITAMIN D RECEPTOR GENE;

CASE-CONTROL STUDIES; CHROMOSOME SEGREGATION; DIABETES MELLITUS, TYPE 2; DISEASE SUSCEPTIBILITY; GENETICS, POPULATION; HLA-DRB1 CHAINS; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; SAUDI ARABIA;

EID: 84856578394     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101954     Document Type: Article

References (54)

1. Iyengar, S., R. F. Hamman, J. A. Marshall, P. P. Majumder, and R. E. Ferrell. 1989. On the role of vitamin D binding globulin in glucose homeostasis: results from the San Luis Valley Diabetes Study. Genet. Epidemiol. 6: 691-698.
2. Ortlepp, J. R., J. Metrikat, M. Albrecht, A. von Korff, P. Hanrath, and R. Hoffmann. 2003. The vitamin D receptor gene variant and physical activity predicts fasting glucose levels in healthy young men. Diabet. Med. 20: 451-454. (Pubitemid 36776004)
3. Pratley, R. E., D. B. Thompson, M. Prochazka, L. Baier, D. Mott, E. Ravussin, H. Sakul, M. G. Ehm, D. K. Burns, T. Foroud, et al. 1998. An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. J. Clin. Invest. 101: 1757-1764. (Pubitemid 28198506)
4. Uitterlinden, A. G., Y. Fang, J. B. van Meurs, H. van Leeuwen, and H. A. Pols. 2004. Vitamin D receptor gene polymorphisms in relation to Vitamin D related disease states. J. Steroid Biochem. Mol. Biol. 89-90: 187-193. (Pubitemid 38844281)
5. Valdivielso, J. M., and E. Fernandez. 2006. Vitamin D receptor polymorphisms and diseases. Clin. Chim. Acta 371: 1-12. (Pubitemid 44162891)
6. Filus, A., A. Trzmiel, J. Kuliczkowska-Płaksej, U. Tworowska, D. Jedrzejuk, A. Milewicz, and M. Medraś. 2008. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. Aging Male 11: 134-139.
7. Naito, M., K. Miyaki, T. Naito, L. Zhang, K. Hoshi, A. Hara, K. Masaki, S. Tohyama, M. Muramatsu, N. Hamajima, and T. Nakayama. 2007. Association between vitamin D receptor gene haplotypes and chronic periodontitis among Japanese men. Int. J. Med. Sci. 4: 216-222. (Pubitemid 47360430)
8. Panierakis, C., G. Goulielmos, D. Mamoulakis, E. Petraki, E. Papavasiliou, and E. Galanakis. 2009. Vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Crete, Greece. Clin. Immunol. 133: 276-281.
9. Bid, H. K., R. Konwar, C. G. Aggarwal, S. Gautam, M. Saxena, V. L. Nayak, and M. Banerjee. 2009. Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study. Indian J. Med. Sci. 63: 187-194.
10. Boucher, B. J., N. Mannan, K. Noonan, C. N. Hales, and S. J. Evans. 1995. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 38: 1239-1245.
11. Kumar, S., M. Davies, Y. Zakaria, E. B. Mawer, C. Gordon, A. O. Olukoga, and A. J. Boulton. 1994. Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D. Postgrad. Med. J. 70: 440-443. (Pubitemid 24196871)
12. Norman, A. W., J. B. Frankel, A. M. Heldt, and G. M. Grodsky. 1980. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209: 823-825. (Pubitemid 10017495)
13. Tanaka, Y., Y. Seino, M. Ishida, K. Yamaoka, H. Yabuuchi, H. Ishida, S. Seino, Y. Seino, and H. Imura. 1984. Effect of vitamin D3 on the pancreatic secretion of insulin and somatostatin. Acta Endocrinol. (Copenh.) 105: 528-533. (Pubitemid 14171181)
14. Ogunkolade, B. W., B. J. Boucher, J. M. Prahl, S. A. Bustin, J. M. Burrin, K. Noonan, B. V. North, N. Mannan, M. F. McDermott, H. F. DeLuca, and G. A. Hitman. 2002. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 51: 2294-2300. (Pubitemid 34729038)
15. Uitterlinden, A. G., Y. Fang, J. B. Van Meurs, H. A. Pols, and J. P. Van Leeuwen. 2004. Genetics and biology of vitamin D receptor polymorphisms. Gene 338: 143-156. (Pubitemid 39094759)
16. Bischoff-Ferrari, H. A., M. Borchers, F. Gudat, U. Dürmüller, H. B. Stähelin, and W. Dick. 2004. Vitamin D receptor expression in human muscle tissue decreases with age. J. Bone Miner. Res. 19: 265-269. (Pubitemid 38116740)
17. Ishida, H., and A.W. Norman. 1988. Demonstration of a high affinity receptor for 1,25-dihydroxyvitamin D3 in rat pancreas. Mol. Cell. Endocrinol. 60: 109-117. (Pubitemid 19005696)
18. Johnson, J. A., J. P. Grande, P. C. Roche, and R. Kumar. 1994. Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas. Am. J. Physiol. 267: E356-E360.
19. Jurutka, P. W., G. K. Whitfield, J. C. Hsieh, P. D. Thompson, C. A. Haussler, and M. R. Haussler. 2001. Molecular nature of the vitamin D receptor and its role in regulation of gene expression. Rev. Endocr. Metab. Disord. 2: 203-216. (Pubitemid 33635523)
20. Zella, J. B., and H. F. DeLuca. 2003. Vitamin D and autoimmune diabetes. J. Cell. Biochem. 88: 216-222. (Pubitemid 36119889)
21. Hutchinson, P. E., J. E. Osborne, J. T. Lear, A. G. Smith, P. W. Bowers, P. N. Morris, P. W. Jones, C. York, R. C. Strange, and A. A. Fryer. 2000. Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin. Cancer Res. 6: 498-504. (Pubitemid 30111470)
22. Todd, J. A., J. I. Bell, and H. O. McDevitt. 1987. HLA-DQ β gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 599-604. (Pubitemid 17140111)
23. Manan, H., A. M. Angham, and A. Sitelbanat. 2010. Genetic and diabetic autoantibody markers in Saudi children with type 1 diabetes. Hum. Immunol. 71: 1238-1242.
24. Williams, R. C., Y. L. Muller, R. L. Hanson, W. C. Knowler, C. C. Mason, L. Bian, V. Ossowski, K. Wiedrich, Y. F. Chen, S. Marcovina, et al. 2011. HLA-DRB1 reduces the risk of type 2 diabetes mellitus by increased insulin secretion. Diabetologia 54: 1684-1692.
25. Pfaffl, M. W., G.W. Horgan, and L. Dempfle. 2002. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30: e36.
26. Israni, N., R. Goswami, A. Kumar, and R. Rani. 2009. Interaction of vitamin D receptor with HLA DRB1 0301 in type 1 diabetes patients from North India. PLoS ONE 4: e8023.
27. Barroso, I. 2005. Genetics of Type 2 diabetes. Diabet. Med. 22: 517-535. (Pubitemid 40593126)
28. Nosratabadi, R., M. K. Arababadi, V. A. Salehabad, A. Shamsizadeh, M. Mahmoodi, A. R. Sayadi, and D. Kennedy. 2010. Polymorphisms within exon 9 but not intron 8 of the vitamin D receptor are associated with the nephropathic complication of type-2 diabetes. Int. J. Immunogenet. 37: 493-497.
29. Motala, A. A., M. Busson, E. M. Al-Harbi, M. A. Khuzam, E. M. Al-Omari, M. R. Arekat, and W. Y. Almawi. 2005. Susceptible and protective human leukocyte antigen class II alleles and haplotypes in bahraini type 2 (non-insulin- dependent) diabetes mellitus patients. Clin. Diagn. Lab. Immunol. 12: 213-217.
30. Almawi, W. Y., S. F. Wakim-Ghorayeb, M. R. Arekat, P. Najm, S. H. Keleshian, N. Al-Sayed, B. Blanchon, H. R. Samaha, and N. Irani-Hakime. 2006. Association of selective HLA class II susceptibility-conferring and protective haplotypes with type 2 diabetes in patients from Bahrain and Lebanon. Clin. Vaccine Immunol. 13: 1296-1298. (Pubitemid 46768888)
31. Speer, G., K. Cseh, G. Winkler, I. Takács, I. Barna, Z. Nagy, and P. Lakatos. 2001. Oestrogen and vitamin D receptor (VDR) genotypes and the expression of ErbB-2 and EGF receptor in human rectal cancers. Eur. J. Cancer 37: 1463-1468. (Pubitemid 32744674)
32. Dilmec, F., E. Uzer, F. Akkafa, E. Kose, and A. B. van Kuilenburg. 2010. Detection of VDR gene ApaI and TaqI polymorphisms in patients with type 2 diabetes mellitus using PCR-RFLP method in a Turkish population. J. Diabetes Complications 24: 186-191.
33. Malecki, M. T., J. Frey, D. Moczulski, T. Klupa, E. Kozek, and J. Sieradzki. 2003. Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population. Exp. Clin. Endocrinol. Diabetes 111: 505-509. (Pubitemid 38101497)
34. Oh, J. Y., and E. Barrett-Connor. 2002. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism 51: 356-359. (Pubitemid 34232638)
35. Kunz, M., and S. M. Ibrahim. 2009. Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity. Mediators Inflamm. 2009: 979258.
36. Kiel, D. P., R. H. Myers, L. A. Cupples, X. F. Kong, X. H. Zhu, J. Ordovas, E. J. Schaefer, D. T. Felson, D. Rush, P. W. Wilson, et al. 1997. The BsmI vitamin D receptor restriction fragment length polymorphism (bb) influences the effect of calcium intake on bone mineral density. J. Bone Miner. Res. 12: 1049-1057. (Pubitemid 27264218)
37. Milner, R. D., and C. N. Hales. 1967. The role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro. Diabetologia 3: 47-49.
38. Ojuka, E. O. 2004. Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle. Proc. Nutr. Soc. 63: 275-278. (Pubitemid 38787478)
39. Wright, D. C., K. A. Hucker, J. O. Holloszy, and D. H. Han. 2004. Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions. Diabetes 53: 330-335. (Pubitemid 38174547)
40. Williams, P. F., I. D. Caterson, G. J. Cooney, R. R. Zilkens, and J. R. Turtle. 1990. High affinity insulin binding and insulin receptor-effector coupling: modulation by Ca2+. Cell Calcium 11: 547-556. (Pubitemid 20336058)
41. Zemel, M. B. 1998. Nutritional and endocrine modulation of intracellular calcium: implications in obesity, insulin resistance and hypertension. Mol. Cell. Biochem. 188: 129-136. (Pubitemid 28493325)
42. Beaulieu, C., R. Kestekian, J. Havrankova, and M. Gascon-Barré. 1993. Calcium is essential in normalizing intolerance to glucose that accompanies vitamin D depletion in vivo. Diabetes 42: 35-43. (Pubitemid 23013793)
43. Yasuda, K., Y. Hurukawa, M. Okuyama, M. Kikuchi, and K. Yoshinaga. 1975. Glucose tolerance and insulin secretion in patients with parathyroid disorders. Effect of serum calcium on insulin release. N. Engl. J. Med. 292: 501-504.
44. Gedik, O., and M. S. Zileli. 1977. Effects of hypocalcemia and theophylline on glucose tolerance and insulin release in human beings. Diabetes 26: 813-819. (Pubitemid 8183528)
45. Gagnon, C., Z. X. Lu, D. J. Magliano, D. W. Dunstan, J. E. Shaw, P. Z. Zimmet, K. Sikaris, N. Grantham, P. R. Ebeling, and R. M. Daly. 2011. Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care 34: 1133-1138.
46. Marshall, T. G. 2006. Are statins analogues of vitamin D? Lancet 368: 1234, author reply 1235.
47. Prüfer, K., and J. Barsony. 2002. Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor. Mol. Endocrinol. 16: 1738-1751. (Pubitemid 34828085)
48. Towers, T. L., T. P. Staeva, and L. P. Freedman. 1999. A two-hit mechanism for vitamin D3-mediated transcriptional repression of the granulocyte-macrophage colony-stimulating factor gene: vitamin D receptor competes for DNA binding with NFAT1 and stabilizes c-Jun. Mol. Cell. Biol. 19: 4191-4199. (Pubitemid 29241993)
49. Wang, T. T., L. E. Tavera-Mendoza, D. Laperriere, E. Libby, N. B. MacLeod, Y. Nagai, V. Bourdeau, A. Konstorum, B. Lallemant, R. Zhang, et al. 2005. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol. Endocrinol. 19: 2685-2695. (Pubitemid 41577243)
50. Ramagopalan, S. V., N. J. Maugeri, L. Handunnetthi, M. R. Lincoln, S. M. Orton, D. A. Dyment, G. C. Deluca, B. M. Herrera, M. J. Chao, A. D. Sadovnick, et al. 2009. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 5: e1000369.
51. Feldman, D., F. H. Glorieux, and J. W. Pike. 2005. Vitamin D. Academic Press, San Diego, CA, London.
52. Louis, P., J. F. Eliaou, S. Kerlan-Candon, V. Pinet, R. Vincent, and J. Clot. 1993. Polymorphism in the regulatory region of HLA-DRB genes correlating with haplotype evolution. Immunogenetics 38: 21-26. (Pubitemid 23098599)
53. Guillot, X., L. Semerano, N. Saidenberg-Kermanac'h, G. Falgarone, and M. C. Boissier. 2010. Vitamin D and inflammation. Joint Bone Spine 77: 552-557.
54. Agliardi, C., F. R. Guerini, M. Saresella, D. Caputo, M. A. Leone, M. Zanzottera, E. Bolognesi, I. Marventano, N. Barizzone, M. E. Fasano, et al. 2011. Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals. Brain Behav. Immun. 25: 1460-1467.